In CE81T cells, shRNA-mediated down-regulation of IL-6 expression resulted in a significantly inhibited tumor growth in vitro and in vivo, attenuated invasive capacity of esophageal cancer cells in migration scratch assays, increased radiation sensitivity, and delayed tumor growth in mice, associated with enhanced DNA damage and reduced STAT3 activation [67]. The gene discussed is STAT3; the disease is neoplasm.